Mouse models of Charcot-Marie-Tooth disease

Trends in Genetics

Volumn 18, Issue 12, 2002, Pages

  Tanaka, Yosuke ^a   Hirokawa, Nobutaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 32; GLYCOPROTEIN; ISOPROTEIN; KINESIN; MYELIN PROTEIN; NEUROFILAMENT PROTEIN; PERIAXIN; PERIPHERAL MYELIN PROTEIN 22; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; CLINICAL FEATURE; CYTOLOGY; DISEASE COURSE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INHERITANCE; MOTOR NERVE CONDUCTION; MOUSE; MUSCLE ATROPHY; NERVE FIBER TRANSPORT; NONHUMAN; NUDE MOUSE; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCHWANN CELL; TRANSGENIC MOUSE; XENOGRAFT;

ANIMALS; CHARCOT-MARIE-TOOTH DISEASE; DISEASE MODELS, ANIMAL; FORECASTING; KINESIN; MICE; MYELIN PROTEINS; MYELIN SHEATH; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; NEURONS; SCHWANN CELLS;

ANIMALIA; MUS MUSCULUS;

EID: 0036890143     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-9525(02)02839-1     Document Type: Review

References (32)

1. Benstead T.J., Grant I.A. Progress in clinical neurosciences: Charcot-Marie-Tooth disease and related inherited peripheral neuropathies. Can. J. Neurol. Sci. 28:2001;199-214.
2. Patel P.I., et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1:1992;159-165.
3. Silander K., et al. A de novo duplication in 17p11.2 and a novel mutation in the Po gene in two Dejerine-Sottas syndrome patients. Hum. Mutat. 8:1996;304-310.
4. Suter U., et al. Trembler mouse carries a point mutation in a myelin gene. Nature. 356:1992;241-244.
5. Vallat J.M., et al. Expression of myelin proteins in the adult heterozygous Trembler mouse. Acta Neuropathol. (Berl.). 98:1999;281-287.
6. Isaacs A.M., et al. Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy. Hum. Mol. Genet. 9:2000;1865-1871.
7. Huxley C., et al. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. Mol. Genet. 5:1996;563-569.
8. Magyar J.P., et al. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 16:1996;5351-5360.
9. Sereda M., et al. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron. 16:1996;1049-1060.
10. Perea J., et al. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Hum. Mol. Genet. 10:2001;1007-1018.
11. Hayasaka K., et al. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P(0) gene. Nat. Genet. 5:1993;31-34.
12. Giese K.P., et al. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell. 71:1992;565-576.
13. Martini R., et al. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat. Genet. 11:1995;281-286.
14. Guilbot A., et al. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum. Mol. Genet. 10:2001;415-421.
15. Gillespie C.S., et al. Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron. 26:2000;523-531.
16. Bergoffen J., et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science. 262:1993;2039-2042.
17. Nelles E., et al. Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 93:1996;9565-9570.
18. Anzini P., et al. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J. Neurosci. 17:1997;4545-4551.
19. Schneider-Maunoury S., et al. Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain. Cell. 75:1993;1199-1214.
20. Topilko P., et al. Krox-20 controls myelination in the peripheral nervous system. Nature. 371:1994;796-799.
21. Sahenk Z., Chen L. Abnormalities in the axonal cytoskeleton induced by a connexin32 mutation in nerve xenografts. J. Neurosci. Res. 51:1998;174-184.
22. Hirokawa N. The neuronal cytoskeleton: roles in neuronal morphogenesis and organelle transport. Molecular Neurobiology: Mechanisms Common to Brain, Skin, and Immune System. 1994;117-143 Wiley-Liss, Inc.
23. Hirokawa N. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science. 279:1998;519-526.
24. Miki H., et al. All kinesin superfamily protein, KIF, genes in mouse and human. Proc. Natl. Acad. Sci. U. S. A. 98:2001;7004-7011.
25. Zhao C., et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bβ Cell. 105:2001;587-597.
26. Mersiyanova I.V., et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet. 67:2000;37-46.
27. Hirokawa N., Takeda S. Gene targeting studies begin to reveal the function of neurofilament proteins. J. Cell Biol. 143:1998;1-4.
28. Cote F., et al. Progressive neuropathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell. 73:1993;35-46.
29. Zhu Q., et al. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp. Neurol. 148:1997;299-316.
30. Vance J.M. The many faces of Charcot-Marie-Tooth disease. Arch. Neurol. 57:2000;638-640.
31. Araki K., et al. Targeted integration of DNA using mutant lox sites in embryonic stem cells. Nucleic Acids Res. 25:1997;868-872.
32. Neuberg D.H. Accelerated demyelination of peripheral nerves in mice deficient in connexin 32 and protein zero. J. Neurosci. Res. 53:1998;542-550.